Kiri Industries DuPont analysis

·ChemicalsChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
0.99×1.00×−2.39×−1.78×−1.19×
−25.14×−20.89×1.12×1.23×1.03×
−24.9%−31.9%−13.3%−6.4%−9.1%
0.14×0.14×0.18×0.29×0.30×
1.09×1.09×1.46×1.21×1.19×
94.1%101.4%9.4%4.9%4.0%
115.0%115.0%8.7%4.9%4.0%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

KIRIINDUS₹521.60

Kiri Industries Limited

· Chemicals
₹ CrorePeersJUBLCPLCHEMPLASTSDDEVPLSTIKROSSARINOCILHSCLTATVANAVINFLUORMcap ₹3,131 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×-1.19-1.78-2.391.000.99
Interest Burden (Pretax/EBIT) ×1.031.231.12-20.89-25.14
EBIT Margin %-9.14-6.40-13.30-31.90-24.85
Asset Turnover ×0.300.290.180.140.14
Financial Leverage (Assets/Equity) ×1.191.211.461.091.09
ROE (5-step product, year-end total equity) %4.044.939.37101.3794.12
ROE (owners' profit / average owners' equity) %3.984.858.74114.97114.97
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.